Article
Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis).
Arthritis research & therapy - 13 Oct 2015
López-Mejías Raquel, Genre Fernanda, Remuzgo-Martínez Sara, Pérez Belén Sevilla, Castañeda Santos, Llorca Javier, Ortego-Centeno Norberto, Ubilla Begoña, Mijares Verónica, Pina Trinitario, Calvo-Río Vanesa, Palmou Natalia, Miranda-Filloy José A, Parejo Antonio Navas, Argila Diego, Sánchez-Pérez Javier, Rubio Esteban, Luque Manuel León, Blanco-Madrigal Juan María, Galíndez-Aguirregoikoa Eva, Ocejo-Vinyals J Gonzalo, Martín Javier, Blanco Ricardo, González-Gay Miguel A
Abstract excerpt
INTRODUCTION: To determine whether the PTPN22 (protein tyrosine phosphatase nonreceptor 22)/CSK (c-src tyrosine kinase) pathway is implicated in the susceptibility and clinical heterogeneity of Henoch-Schönlein purpura (HSP) in the largest series of Caucasian HSP patients ever assessed for genetic studies. METHODS: A set of 329 Spanish patients diagnosed with HSP fulfilling the American College of Rheumatology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
